Concepedia

Matthew B. Yurgelun

MB

Statistics

Publications

62

Citations

6.3K

H-Index

34

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Dana-Farber Brigham Cancer Center

Matthew B. Yurgelun is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and cancer genetics.

Publications per year

2004–2024

62

Publications

62

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Mary B. Daly, Tuya Pal, Michael P. Berry et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs et al. · Journal of Clinical Oncology · 2017 · 519 citations · Full text

Life Sciences, Genetics, Oncology +17

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020

Mary B. Daly, Robert Pilarski, Matthew B. Yurgelun et al. · Journal of the National Comprehensive Cancer Network · 2020 · 507 citations · Full text

Life Sciences, Genetics, Oncology +17

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda et al. · Cancer Discovery · 2018 · 369 citations · Full text

Medicine, Oncology, Dna Repair +10

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Mary B. Daly, Tuya Pal, Kara N. Maxwell et al. · Journal of the National Comprehensive Cancer Network · 2023 · 290 citations · Full text

Life Sciences, Genetics, Oncology +17

1–5 of 62